Working to Eradicate Gynecologic Cancers

Joan Leslie Walker, MD

Professor, James A. Merrill Chair, Gynecologic Oncology
The University of Oklahoma
Dept. of OB/GYN
800 NE 10th St
Suite 5050
Oklahoma City, OK
USA 73104


Biographical Sketch:
GOG Co-Chair cancer prevention and control. PI NCI SUCCEED BIOMARKERS IN CERVICAL CANCER. Currently driving toward ovarian cancer risk reduction with OCP And salpingectomy followed by oophorectomy in high risk women. Salpingectomy alone in average risk women.

Papers:
116 Provision of primary palliative care by gynecologic oncologists 486 Identifying gynecologic oncology patients with high symptom burden A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian A phase II evaluation of sunitinib (SU11248) in the treatment of persistent or recurrent clear cell ovarian carcinoma: an NRG oncology / gynecologic oncology group study